Research article

Nargenicin A1 attenuates lipopolysaccharide-induced inflammatory and oxidative response by blocking the NF-κB signaling pathway

Da Hye Kwon1,2, Gi-Young Kim3, Hee-Jae Cha4, Suhkmann Kim5, Heui-Soo Kim6, Hye-Jin Hwang7, Yung Hyun Choi1[*],2

1Anti‐Aging Research Center, Dong‐eui University, Busan, Republic of Korea

2Department of Biochemistry, Dong‐eui University College of Korean Medicine, Busan, Republic of Korea

3Department of Marine Life Science, School of Marine Biomedical Sciences, Jeju National University, Jeju, Republic of Korea

4Department of Parasitology and Genetics, College of Medicine, Kosin University, Busan, Republic of Korea

5Department of Chemistry, College of Natural Sciences, Pusan National University, Busan, Republic of Korea

6Department of Biological Sciences, College of Natural Sciences, Pusan National University, Busan, Republic of Korea

7Department of Food and Nutrition, College of Nursing, Healthcare Sciences & Human Ecology, Dong-eui University, Busan, Republic of Korea

EXCLI J 2025;24:Doc452

 

Corrigendum

Corrigendum to original article

Nargenicin A1 attenuates lipopolysaccharide-induced inflammatory and oxidative response by blocking the NF-κB signaling pathway

EXCLI Journal 2021;20:968-982

Correction of duplicated figures in http://dx.doi.org/10.17179/excli2021-3506

In the article "Nargenicin A1 attenuates lipopolysaccharide-induced inflammatory and oxida-tive response by blocking the NF-κB signaling pathway" published in EXCLI Journal (EXCLI J. 2021 May 28;20:968-982. doi: 10.17179/excli2021-3506), a duplication error was identified in Figures 1 and 2. Both figures, though described differently in their figure legends, were found to be identical. Figure 1 should be: (Fig. 1)

Figure 2 is correct.

Editorial Office/EXCLI Journal on behalf of the corresponding author

This is an Open Access article distributed under the terms of the Creative Commons Attribution License
http://creativecommons.org/licenses/by/4.0/.

 
 

[*] Corresponding Author:

Yung Hyun Choi, Department of Biochemistry, Dong-eui University College of Korean Medicine, 52-57, Yangjeong-ro, Busan 47227, Republic of Korea; Tel: 82-51-890-3319, Fax: +82-51-890-3333, eMail: choiyh@deu.ac.kr

Figure 1: Effect of nargenicin A1 and LPS on the cell viability of RAW 264.7 macrophages. Cells were treated with various concentrations of nargenicin A1 alone for 24 h or pre-treated with or without nargenicin A1 for 1 h before 100 ng/ml LPS stimulation for 24 h. Cell viability was analyzed using the MTT assay. H2O2 was used as a positive control. Each value indicates the mean ± SD and is representative of three independent experiments. Significant differences among the groups were determined (***p < 0.001, vs. LPS-unstimulated cells).